Ian Karp | Senior Vice President, Investor and Public Relations |
Michael Kauffman | Chief Executive Officer |
Michael Mason | Chief Financial Officer |
John Demaree | Chief Commercial Officer |
Stephen Mitchener | Chief Business Officer |
Jatin Shah | Chief Medical Officer |
Maury Raycroft | Jefferies |
Brian Abrahams | RBC Capital Markets |
Peter Lawson | Barclays |
Jonathan Chang | SVB Leerink |
Michael Ulz | Baird |
Edward White | H.C. Wainwright |
Good morning. My name is Vaishnavi, and I will be your conference operator for today. At this time, I would like to welcome everyone to Karyopharm Therapeutics' Fourth Quarter and Full Year 2020 Financial Results Conference Call. [Operator Instructions] Please be advice that this call is being recorded at the company's request. I would now like to turn the call over to Mr.